Iscare i.v.f., Czech Republic Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT01765439
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

ISCARE Clinic, Praha, Czech Republic

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 6